Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Compelling evidence demonstrated that melatonin increases p53 activity in cancer cells. p53 undergoes acetylation to be stabilized and activated for driving cells destined for apoptosis/growth inhibition. Over‐expression of p300 induces p53 acetylation, leading to cell growth arrest by increasing p21 expression. In turn, p53 activation is mainly regulated in the nucleus by MDM 2. MDM 2 also acts as E3 ubiquitin ligase, promoting the proteasome‐dependent p53 degradation. MDM 2 entry into the nucleus is finely tuned by two different modulations: the ribosomal protein L11, acts by sequestering MDM 2 in the cytosol, whereas the PI 3K‐AkT‐dependent MDM 2 phosphorylation is mandatory for MDM 2 translocation across the nuclear membrane. In addition, MDM 2‐dependent targeting of p53 is regulated in a nonlinear fashion by MDM 2/MDMX interplay. Melatonin induces both cell growth inhibition and apoptosis in MCF 7 breast cancer cells. We previously reported that this effect is associated with reduced MDM 2 levels and increased p53 activity. Herein, we demonstrated that melatonin drastically down‐regulates MDM 2 gene expression and inhibits MDM 2 shuttling into the nucleus, given that melatonin increases L11 and inhibits Akt‐PI 3K‐dependent MDM 2 phosphorylation. Melatonin induces a 3‐fold increase in both MDMX and p300 levels, decreasing simultaneously Sirt1, a specific inhibitor of p300 activity. Consequently, melatonin‐treated cells display significantly higher values of both p53 and acetylated p53. Thus, a 15‐fold increase in p21 levels was observed in melatonin‐treated cancer cells. Our results provide evidence that melatonin enhances p53 acetylation by modulating the MDM 2/MDMX/p300 pathway, disclosing new insights for understanding its anticancer effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 1×
“In an experimental model, artificial over-expression of MDM2 up to a hundredfold or more greater than normal was shown to produce a transformed phenotype, but its biochemical function remained a mystery until the phosphorylated form of MDM2 was discovered and recognized to interact with p53 [29].”
BackgroundRescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“The importance of MDM2 in controlling p53 functions is well documented by studies performed on MDM2 knockdown animals, in which the loss of MDM2 leads to uncontrolled p53 activity and subsequent embryonic lethality [25].”
BackgroundRegulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-973 · Cited by 951 · cited 1×
“As previously reported by several authors [30, 31], melatonin slightly but significantly slowed down the activity of the PI3K/AkT pathway, leading to a relevant reduction in MDM2p levels.”
BackgroundAcetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Inhibiting the p53–MDM2 interaction: an important target for cancer therapy
Chène, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc991 · Cited by 765
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · cited 1×
“Eventually, MDM2 activity is modulated by its interaction with MDMX, a p53-binding protein sharing considerable homology with MDM2 [33].”
BackgroundMDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · cited 1×
“Indeed, at least 10% of human cancers display unusual MDM2 over-expression, due to either gene amplification or transcriptional/posttranscriptional mechanisms [26, 27].”
BackgroundMDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570 · cited 1×
“On the contrary, acetylation is not only required to protect p53 from MDM2-dependent degradation [11], but p53 obligatorily becomes acetylated following cellular and biochemical insults known to be potent p53-activating agents [12].”
Background
Cited by
Melatonin: an inhibitor of breast cancer
Hill, S. M., Belancio, V. P., Dauchy, R. T., Xiang, S., Brimer, S., Mao, L., Hauch, A., Lundberg, P. W., Summers, W., Yuan, L., et al. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0030 · Cited by 317
Melatonin feedback on clock genes: a theory involving the proteasome
Vriend, J., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12189 · Cited by 264
Self-citationMelatonin and sirtuins: A “not-so unexpected” relationship
Mayo, J. C., Sainz, R. M., González Menéndez, P., Cepas, V., Tan, D., & Reiter, R. J. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12391 · Cited by 175
Self-citationZhou, L., Chen, X., Liu, T., Gong, Y., Chen, S., Pan, G., Cui, W., Luo, Z., Pei, M., Yang, H., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12250 · Cited by 158
Gelaleti, G. B., Borin, T. F., Maschio-Signorini, L. B., Moschetta, M. G., Jardim-Perassi, B. V., Calvinho, G. B., Facchini, M. C., Viloria-Petit, A. M., & de Campos Zuccari, D. A. P. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.013 · Cited by 35
Metadata
- Authors
- Proietti, S., Cucina, A., Dobrowolny, G., D'Anselmi, F., Dinicola, S., Masiello, M. G., Pasqualato, A., Palombo, A., Morini, V., Reiter, R. J., & Bizzarri, M.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2014-07-10
- Volume
- 57
- Issue
- 1
- Pages
- 120-129
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2136429046
- Cited by
- 96
- References
- 16
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells. https://app.cochat.ai/papers/10.1111/jpi.12150
- The paper
- Proietti, S., Cucina, A., Dobrowolny, G., D'Anselmi, F., Dinicola, S., Masiello, M. G., Pasqualato, A., Palombo, A., Morini, V., Reiter, R. J., & Bizzarri, M. (2014). Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells. Journal of Pineal Research. https://doi.org/10.1111/jpi.12150
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.